Evidence map›Paper›PMID 29267878›Full record

ArticleBioinformatics (Oxford, England)2018

Computational identification of micro-structural variations and their proteogenomic consequences in cancer.

Yen-Yi Lin, Alexander Gawronski, Faraz Hach, Sujun Li, Ibrahim Numanagic, Iman Sarrafi, Swati Mishra, Andrew McPherson, Colin C Collins, Milan Radovich and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Yen-Yi LinSchool of Computing Science, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
Alexander GawronskiSchool of Computing Science, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
Faraz HachSchool of Computing Science, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
Sujun LiDepartment of Computer Science, Indiana University, Bloomington, IN 47405, USA.
Ibrahim NumanagicSchool of Computing Science, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
Iman SarrafiSchool of Computing Science, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
Swati MishraDepartment of Surgery, Indiana University, School of Medicine, Indianapolis, IN 46202, USA.
Andrew McPhersonSchool of Computing Science, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
Colin C CollinsVancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.
Milan RadovichDepartment of Surgery, Indiana University, School of Medicine, Indianapolis, IN 46202, USA.
Haixu TangDepartment of Computer Science, Indiana University, Bloomington, IN 47405, USA.
S Cenk SahinalpVancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.
Simon Fraser University · CAIndiana University Bloomington · USIndiana University – Purdue University Indianapolis · USUniversity of British Columbia · CA

Funding

Compressive genomics for large omics data sets: Algorithms applications & toolsR01GM108348 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BERGER, BONNIE · 2013 to 2019
$2.1M
Computational approaches to protein identification and quantification using MS/MSR01GM103725 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI RADIVOJAC, PREDRAG · 2012 to 2015
$1.7M
NIGMS NIH HHS R01 GM103725NIGMS NIH HHS R01 GM108348
6 · The paper itself

Abstract

Motivation: Rapid advancement in high throughput genome and transcriptome sequencing (HTS) and mass spectrometry (MS) technologies has enabled the acquisition of the genomic, transcriptomic and proteomic data from the same tissue sample. We introduce a computational framework, ProTIE, to integratively analyze all three types of omics data for a complete molecular profile of a tissue sample. Our framework features MiStrVar, a novel algorithmic method to identify micro structural variants (microSVs) on genomic HTS data. Coupled with deFuse, a popular gene fusion detection method we developed earlier, MiStrVar can accurately profile structurally aberrant transcripts in tumors. Given the breakpoints obtained by MiStrVar and deFuse, our framework can then identify all relevant peptides that span the breakpoint junctions and match them with unique proteomic signatures. Observing structural aberrations in all three types of omics data validates their presence in the tumor samples. Results: We have applied our framework to all The Cancer Genome Atlas (TCGA) breast cancer Whole Genome Sequencing (WGS) and/or RNA-Seq datasets, spanning all four major subtypes, for which proteomics data from Clinical Proteomic Tumor Analysis Consortium (CPTAC) have been released. A recent study on this dataset focusing on SNVs has reported many that lead to novel peptides. Complementing and significantly broadening this study, we detected 244 novel peptides from 432 candidate genomic or transcriptomic sequence aberrations. Many of the fusions and microSVs we discovered have not been reported in the literature. Interestingly, the vast majority of these translated aberrations, fusions in particular, were private, demonstrating the extensive inter-genomic heterogeneity present in breast cancer. Many of these aberrations also have matching out-of-frame downstream peptides, potentially indicating novel protein sequence and structure. Availability and implementation: MiStrVar is available for download at https://bitbucket.org/compbio/mistrvar, and ProTIE is available at https://bitbucket.org/compbio/protie. Contact: cenksahi@indiana.edu. Supplementary information: Supplementary data are available at Bioinformatics online.

Indexed as

Gene FusionSoftwareBreast NeoplasmsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMass SpectrometryNeoplasm ProteinsProteogenomicsSequence Analysis, RNANeoplasm Proteins

Identifiers

PMID29267878
PMCPMC5946953
OpenAlexW2773943265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.